Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
BioMed Research International , 2015, 648108
Jalalian H
At HyperCharge Health in Edina, MN, we believe biology is always listening
Tesamorelin Peptide Regulatory Status in Canada Health Canada Approval Status (Egrifta and Egrifta SV) Tesamorelin is the active ingredient in Egrifta, an approved prescription drug product authorized by Health Canada under a Notice of Compliance issued April 29, 2014, to Theratechnologies Inc
For direct purchases, the company's return policy applies only to unopened and unused products (and Amazon doesnt accept returns on supplements at all)
Titration Plan (Once Daily) Gradual titration on a 20 mg blend reconstituted with 3.0 mL BAC water Week Weeks 1-2 Dose (each peptide) 100 mcg Insulin units 3 units Volume 0.03 mL Week Weeks 3-4 Dose (each peptide) 150 mcg Insulin units 4.5 units Volume 0.045 mL Week Weeks 5-8 Dose (each peptide) 200 mcg Insulin units 6 units Volume 0.06 mL Week Weeks 9-12 Dose (each peptide) 200-300 mcg Insulin units 6-9 units Volume 0.06-0.09 mL These are research-planning ranges drawn from common protocol summaries (Teichman 2006 dosing studied CJC-1295 with DAC, not no-DAC)
US$ 25.29
US$ 24.06
US$ 27.11
US$ 22.76
